期刊文献+

3.0T MR扩散张量成像在胶质瘤分级中的临床诊断价值 被引量:6

To Evaluate the Value of 3.0 MR Diffusion Tensor Imaging in Cerebral Glioma Grading
下载PDF
导出
摘要 目的探讨MR扩散张量成像在胶质瘤分级中的研究价值。方法 31例胶质瘤患者行3.0T MR常规及扩散张量成像(DTI)检查,定量测量各向异性系数FA及表观弥散系数值(ADC),对低级别、高级别胶质瘤组间定量参数的比较采用Mann-Whitney U检验。以肿瘤ROI中ADC与FA值作为临界点绘制出ROC曲线,计算曲线下面积,确定诊断阈值,评价其诊断效能。结果 14例低级别胶质瘤的FA值为(139.4±81.3);ADC值为(1.36±0.21)×10-3mm2/s;17例高级别胶质瘤FA值为(103.1±41.5),ADC值为(1.09±0.28)×10-3mm2/s.;2两组间参数差异有统计学意义(P<0.05)。以ADC值作为临界点判断肿瘤低高级并绘制ROC曲线,曲线下面积为0.79。以ADC值等于1.11×10-3mm2/s作为诊断阈值,区分低高级肿瘤的敏感度为58.8%,特异度为92.9%。以FA值作为临界点判断肿瘤低高级并绘制ROC曲线,曲线下面积为0.62。以FA值等于178.9作为诊断阈值,区分低高级肿瘤的敏感度为94.1%,特异度为35.7%。结论 DTI中FA值及ADC值对胶质瘤病理分级有重要的评估价值。 Objective To evaluate the value of diffusion tensor cerebral glioma grading at 3.0T. Methods Thirty-one patients confirmed cerebral glioma underwent DTI measurement. The values of FA of tumor tissues were measured and were correlated to the grade of cerebral gliomas by Kruskal- Wallis H test. ROC analysis was used to assess the FA and ADC to distinguish between low-grade glioma (LGG) and high grade glioma (HGG). Results The FA values were (139.4±81,3) and (103.1 ± 41.5) for LGG) and HGG, respectively. The ADC values were (1.36 ± 0.21)×10^-3mm^2/s and (1.09 ± 0.28)×10^-3mm^2/s for LGG and HGG, respectively. Statistical significance of FA and ADC values were found between LGG and HGG (P〈0.05). Area under curve (AUC) of ADC/FA was 0.79/0.62, the sensitivity was 58.8%/94.1% and the specificity, was 92.9%/35.7%, with a threshold value of 1.11×10^-3(mm^2)/178.9. Conclusion The DTI parameter-FA and ADC have the potential clinical importance for cerebral glioma grading.
出处 《中国CT和MRI杂志》 2017年第10期14-17,F0002,共5页 Chinese Journal of CT and MRI
关键词 胶质瘤 MR动态增强扫描 扩散张量成像 病理学 Cerebral Glioma Diffusion Tensor Imaging Pathology
  • 相关文献

参考文献3

二级参考文献28

  • 1索新,郭永川,孟令秋,郭宏川.血管内皮生长因子在人脑胶质瘤的定位及表达[J].中华实验外科杂志,2004,21(9):1100-1102. 被引量:8
  • 2史瑞华,漆剑频,王承缘.扩散张量各向异性分数在星形细胞瘤中的诊断价值[J].中国医学影像技术,2005,21(7):1006-1008. 被引量:7
  • 3Chen J, Li Y, Yu TS, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 2012, 488(7412): 522-526.
  • 4Westermark B. Glioblastoma-a moving target. Ups J Med Sci, 2012, 117(2): 251-256.
  • 5Van Gool S, Maes W, Ardon H, et al. Dendritic cell therapy ofhigh-grade gliomas. Brain Pathol, 2009, 19(4): 694-712.
  • 6Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase IIl study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol, 2009, 10(5): 459-466.
  • 7Stadlbauer A, Ganslandt O, Buslei R, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology, 2006, 240(3): 803-810.
  • 8Kinoshita M, Hashimoto N, Goto T, et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage, 2008, 43(1): 29-35.
  • 9Lee E J, Lee SK, Agid R, et al. Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. Am J Neuroradiol, 2008, 29(10): 1872-1877.
  • 10Goebell E, Paustenbach S, Vaeterlein O, et al. Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology, 2006, 239(1): 217-222.

共引文献103

同被引文献49

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部